- Q1 2024 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$5.36 (-2.19%)Earnings
- Q4 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2024$3.64 (-2.41%)Earnings
- Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023$4.33 (-2.26%)Earnings
- Q2 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptJul 27, 2023$6.46 (-0.77%)Earnings
- Q1 2023 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2023$6.39 (-0.47%)Earnings
- Q4 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 08, 2023$7.15 (-5.42%)Earnings
- Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2022$10.31 (-3.10%)Earnings
- Q2 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2022$10.8 (+3.55%)Earnings
- Vanda Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$9.8 (-4.20%)Earnings
- Q4 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 23, 2022$13.07 (-2.46%)Earnings
- Q3 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021$21.14 (+2.67%)Earnings
- Q2 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptJul 28, 2021$19.53 (+1.19%)Earnings
- Vanda Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$16.58 (-0.48%)Earnings
- Q4 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 10, 2021$15.41 (-0.58%)Earnings
- Q3 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptOct 28, 2020$10.09 (-4.77%)Earnings
- Q2 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020$11.02 (+1.75%)Earnings
- Vanda Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 11, 2020
- Q1 2020 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020$11.69 (-0.51%)Earnings
- Q4 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2020$11.47 (-2.42%)Earnings
- Q3 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptNov 06, 2019$13.14 (-2.67%)Earnings
- Q2 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptJul 31, 2019$12.45 (-1.58%)Earnings
- Q1 2019 Vanda Pharmaceuticals Inc Earnings Call TranscriptMay 01, 2019$16 (-1.78%)Earnings
Vanda Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript
The afternoon session of the BofA Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA. We're thrilled today to have Vanda Pharmaceuticals, and speaking on behalf of Vanda is CFO, Kevin Moran. Kevin?
Good afternoon, everyone, and thank you very much, Geoff, for the introduction and the invitation. Very excited to share our progress with everyone here.
Great. Here are our forward-looking statements that we'd like for folks to review and be aware of.
So Vanda has 2 commercialized products, HETLIOZ and Fanapt. HETLIOZ comes in 2 forms, oral capsules and liquid formulation. Oral capsules are approved in the U.S. and Europe for the treatment of Non-24-hour sleep wake disorder. HETLIOZ oral capsules and HETLIOZ LQ, the liquid formulation, are also approved for the treatment of nighttime sleep disturbances in adults and children, respectively,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)